Restrictions and Mandatory Procedures for Entry into the Destinations

The SATA Group airlines have been permanently monitoring the national and international developments related to the Covid-19 outbreak and have complied with all the recommendations issued by the competent national and international entities, namely IATA (International Air Transport Association), the World Health Organization (WHO), the European Centre of Disease Prevention and Control, as well as the National and Regional Directorate of Health and also the national aeronautical entity, ANAC.

Click here for IATA recommendations on restrictions and entry procedures at destinations.

 

Select your destination:

 

 

 

COVID-19 screening test with negative result Mandatory on arrival
Completion of a questionnaire with health and travel information Mandatory

 

Mandatory information that passengers must provide

 

MySafeAzores.com. Your arrival to the Azores will be faster and easier!

 

Passengers must fill in the MySafeAzores questionnaire and submit the laboratory test result or the test certificate within 72 hours before the start of their trip, whose code generated by the MySafeAzores platform will be validated at the arrival in the Azores. Passengers aged 12 and under, although exempt from test and its submission upon arrival in the Azores, must also fill out the MySafeAzores form.

 

Restrictions and prevention measures applied by the authorities


Travel originating from abroad

1. Until January 9. 2022, all passengers aged 12 and over on international flights to or transiting the Autonomous Region of the Azores must present to the airline, before boarding, proof of a laboratory nucleic acid amplification test (NAAT) or rapid antigen test (TRAg) for screening for SARS-CoV-2 infection with negative results, carried out within 72 or 48 hours before departure, respectively, or the EU Digital COVID Certificate in the form of a test or recovery certificate, as provided in paragraph b) and c), respectively, of point 6 below, without which they will not be allowed to board.
 

2. Until January 9, 2022, presentation of proof of vaccination does not exempt the requirement to submit proof of a negative test result.
 

3. The proof of laboratory performance of the rapid antigen test (TRAg) must contain the standard data set defined by the European Union Health Security Committee. Only tests from the general list of rapid antigen tests for COVID-19 screening within the European Union agreed by this Health Security Committee are allowed.

 

Travel originating in the national territory

1. Passengers who intend to travel from any part of the national territory to the Autonomous Region of the Azores must perform a mandatory diagnostic test for SARS-CoV-2 upon arrival at the island of final destination.
 

2. The following are exempted from the requirement of testing for SARS-CoV-2 upon entry into the Region:

  1. Passengers who present a valid European Union COVID digital vaccination certificate or an International Vaccination Certificate from the World Health Organization, as of July 1, 2021.
     
  2. Passengers who present a valid European Union COVID digital test certificate, either digitally or on paper;
     
  3. Passengers presenting the valid European Union COVID digital recovery certificate with its QR code, as of July 1, 2021, or a declaration of clinical discharge from surveillance and isolation measures issued by the public health service regarding SARS-CoV-2, which is valid for 180 days;
     
  4. Passengers who present proof of a negative result of a nucleic acid amplification test (NAAT) or rapid antigen test (RAT) for SARS-CoV-2 infection, performed within 72 hours or 48 hours prior to boarding;
     
  5. Passengers aged 12 years and under;
     
  6. Health professionals on duty for transferring or evacuating patients with an updated professional periodic screening, under the technical standard of the Regional Health Authority in effect at the date of travel;
     
  7. Passengers with a disease duly confirmed by a medical statement attesting to anatomical and/or clinical incompatibility for conducting a SARS-CoV-2 diagnostic test through nasopharynx swab. In this case, passengers must submit, at least five working days before their trip, the mentioned declaration to the Regional Health Authority for validation, without prejudice of conducting a serological test upon arrival in the Azores;
     
  8. Airline crews that do not move from the airside to the landside of the airport, as well as those who travel in service outside the Azores and return without having left the aircraft;
     

2.1. These exception declarations may only be submitted in paper or digital format, excluding the SMS format.
 

3. The document issued by the laboratory that performs the SARS-CoV-2 diagnostic test must include, in Portuguese or English, the passenger’s identification; the name of the laboratory where the test was performed with mention to its certification; the reference to the use of any of the methodologies mentioned in paragraph d) of the previous point; the reference to "nasopharyngeal or oropharyngeal swab" sample, "nasopharyngeal or oropharyngeal exudate", "respiratory sample" or "respiratory exudate"; the test date; and its NEGATIVE result.
The document proving the negative test done at origin or upon arrival in the Azores is valid for travel to other islands in the archipelago.
 

4. All passengers must comply with the rules on wearing a mask, physical distance, and respiratory hygiene set by the regional health authority.

 

These guidelines do not exempt the careful reading of Articles 4 and 5 of Government Council Resolution no. 278/2021 of December 2, 2021 and Chapter IV of the Council of Ministers Resolution No. 157-A/2021.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 


 

Inter-island travel


Restrictions and prevention measures applied by the authorities

1. All passengers traveling from airports on islands in the archipelago of the Azores where there is community transmission of the SARS-CoV-2 virus with an incidence rate higher than seventy-five new positive cases per 100,000 inhabitants in the last seven days to any other island are subject to testing on arrival at the island of their final destination, except if they present:
 

  1. Proof, in digital format, except SMS, or on paper, of a valid EU COVID digital testing certificate;
     
  2. Proof, in digital format, excluding SMS, or paper, of a document issued by a duly certified national or international laboratory, attesting to the performance of a screening test for SARS-CoV-2, using the RT-PCR methodology, within 72 hours before the flight departure.
     
  3. Proof, in digital form except SMS, or on paper, of a certificate stating that the passenger has undergone a rapid antigen test included in the list drawn up by the European Commission based on the Council Recommendation of 21 January 2021 on a common framework for the use and validation of rapid antigen detection tests for COVID-19 and the mutual recognition of the test results within the EU, within the last 48 hours, with a negative result.

You can find the levels of transmission risk in the islands of the Azores here.

 

2. The document issued by the laboratory must contain the passenger's identification, the name of the laboratory where the test was performed with mention to its certification, the reference to the use of the RT-PCR methodology, the test date, and its NEGATIVE result.
 

Check here the laboratories convened with the Regional Government of the Azores for this purpose.

 

3. This is not mandatory in the following situations:

  • Passengers who present a valid EU COVID Digital Vaccination Certificate or an International Vaccination Certificate from the World Health Organization, as of July 1, 2021;
     
  • Vaccination certificate issued by third countries, under conditions of reciprocity, containing the following information:
    1. First name(s) and surname(s) of the holder;
    2. Date of birth;
    3. Disease or agent targeted: COVID-19 (SARS-CoV-2 or one of its variants);
    4. COVID-19 vaccine or prophylaxis;
    5. Name of the COVID-19 vaccine;
    6. Marketing authorization holder or manufacturer of the COVID-19 vaccine;
    7. Number in a series of doses as well as the total number of doses in the series;
    8. Date of vaccination, indicating the date of the last dose administered;
    9. Member State or third country in which the vaccine was administered;
    10. Entity issuing the certificate.
       
  • The validity of the issued vaccination certificates shall only be recognized if their holders have been inoculated with a vaccine against COVID-19 with marketing authorization under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004, namely:
     
    1. Janssen: COVID-19 Vaccine Janssen;
    2. AstraZeneca: Vaxzevria (formerly COVID-19 Vaccine AstraZeneca);
    3. Moderna: Spikevax (formerly COVID-19 Vaccine Moderna);
    4. Pfizer-BioNTech: Comirnaty.
       
  • Passengers presenting the valid EU COVID Digital Recovery Certificate with its QR code, as of July 1, 2021, or a declaration of clinical discharge from surveillance and isolation measures issued by the public health service regarding SARS-CoV-2, which is valid for 180 days;
     
  • Passengers aged 12 years or under;
     
  • Health professionals on duty for the transfer or evacuation of patients and who have the periodic professional-level screening updated, according to the technical standard of the Regional Health Authority in effect;
     
  • Passengers with an illness duly proven by a medical declaration attesting the anatomical and/or clinical incompatibility to perform the SARS-CoV-2 diagnostic test, through the collection of biological material by the nasopharynx, in which case passengers must previously submit the said declaration to the Regional Health Authority for validation, at least two working days in advance, without prejudice to performing a serological test upon arrival on the island of destination;
     
  • Passengers departing from an island considered to have a lower risk of transmission and, in transit to the island of final destination, land at airports on islands classified as high or medium risk of transmission, as long as they do not circulate from the airside area to the landside area;
     
  • Airline crews that do not circulate from the airport's airside area to the landside area, as well as those that travel on duty, departing from islands classified as having a higher risk of transmission and return to them without having left the aircraft.
     

3.1. These exception declarations may only be submitted in paper or digital format, excluding the SMS format.

 

These guidelines do not exempt the careful reading of Articles 4 and 5 of Government Council Resolution no. 238/2021 of September 29, 2021.
 

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
Need for prophylactic isolation / quarantine May be applicable

 

Mandatory information that passengers must provide

All passengers disembarking at Madeira Airports must complete the traveler’s registration form in the web app Madeira Safe to Discover web app registration through the address www.madeirasafe.com.

 

Restrictions and prevention measures applied by the authorities

  • 1. All passengers on flights originating from any territory outside of the Autonomous Region of Madeira, except for passengers carrying a European Union COVID Digital Certificate, are required to comply, alternatively, with the following:
     
    • 1.1. Present proof of a negative result from an Antigen Test for SARS-CoV-2 infection, performed within 48 hours before boarding;
       
    • 1.2. Perform, upon landing, an Antigen Test for SARS-CoV-2 infection, to be promoted by the health authority, and ensure full compliance with surveillance and self-reporting of symptoms and COVID-19 prevention measures until a negative result from the test is obtained;
       
    • 1.3. Comply with isolation, for a period of 10 days, at home or at the hotel where they are staying, and if the stay is less than 10 days, the confinement will last for the duration of the stay;
       
    • 1.4. Not disembark, or return to the place of origin or any other destination outside the territory of the Autonomous Region of Madeira, complying, until the time of departure, with isolation at home or at the hotel establishment where they are staying;
       
    • 1.5. Exceptions:
       
      1. Children under 11 years of age;
         
      2. Passengers who have a medical document certifying that the bearer has recovered from COVID-19 upon landing in the Autonomous Region of Madeira, issued within the last 180 days, or a document certifying that the bearer has been vaccinated against COVID-19 under the recommended plan and respecting the activation period of the immune system.
         
      3. Passengers carrying a document certifying that the holder has been vaccinated with only one dose (in vaccination programs of two doses), respecting the activation period of the immune system, in the case of patients recovered from SARS-CoV-2 infection (after 180 days from the date of recovery) or diagnosed with the disease after the first dose of the vaccine;
         
     
  • 2. All travelers who are residents in the territory of the Autonomous Region of Madeira, as well as Madeiran emigrants, their families, and students attending higher education establishments located in or outside the Autonomous Region of Madeira, or in Mobility Programs, who disembark in Madeira and Porto Santo airports in flights arriving from any territory outside the Autonomous Region of Madeira, must perform a second Antigen test for SARS-CoV-2, between the fifth and seventh days after the first test, and must ensure, in the period between landing and the second test, full compliance with surveillance and self-reporting of symptoms and COVID-19 prevention measures, until the second test result is obtained.
     

These guidelines do not exempt the careful reading of Articles 8 and following of Resolution No. 977/2021 of October 14, 2021.

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
portugalcleanandsafe.pt
Need for prophylactic isolation / quarantine Mandatory (see paragraph 7)

 

Restrictions and prevention measures applied by the authorities

 

1. Flights to and from South Africa, Botswana, Eswatini, Lesotho, Mozambique, Namibia, and Zimbabwe are suspended.
 

2. Essential and non-essential travel to and from mainland Portugal is authorized:
 

  1. For passengers coming from the Member States of the European Union, to and from countries associated with the Schengen area (Liechtenstein, Norway, Iceland, and Switzerland);
     
  2. For passengers coming from Brazil, the United States of America and the United Kingdom;
     
  3. For passengers holding an EU COVID Digital Certificate, in digital or paper form, and passengers holding a digital certificate for a COVID-19 vaccine with marketing authorization which has been the subject of a European Commission implementing decision;
     
  4. For passengers possessing proof of vaccination attesting that the vaccination schedule has been completed, for at least 14 days, with a vaccine against COVID-19 with marketing authorization. Vaccination or recovery certificates issued by third countries are recognized as valid, subject to reciprocity;
     
  5. For passengers arriving from Argentina, Australia, Bahrain, Canada, Chile, Colombia, Indonesia, Kuwait, New Zealand, People's Republic of China, Peru, Qatar, Republic of South Korea, Rwanda, Saudi Arabia, United Arab Emirates, Uruguay, and Taiwan, and the special administrative regions of Hong Kong and Macau, whose epidemiological situation is under Council Recommendation (EU) 2020/912 of June 30, 2020, and its updates, subject to reciprocity confirmation, or passengers arriving from these countries via any other of these countries;

 

3. Essential travel by passengers from other countries is also allowed, namely:

  1. Travel for professional, study, family, health or humanitarian reasons;
     
  2. Travel to support the return of national citizens or holders of residence permits in Portugal, which have been recognized by the competent services of the governmental area of foreign affairs and by the competent authorities for civil aviation;
     
  3. Travel to allow the return to the respective countries of foreign citizens, who are in Portugal, provided that the competent authorities of those countries promote such flights, subject to a prior request and agreement, and respecting the principle of reciprocity.

 

4. Foreign citizens without legal residence in national territory transiting through a national airport must wait for the connecting flight to the respective countries in a dedicated place inside the airport.

 

5. Until January 9. 2022, all passengers on international flights to or transiting mainland Portugal must present to the airline, before boarding, proof of a laboratory nucleic acid amplification test (NAAT) or rapid antigen test (TRAg) for screening for SARS-CoV-2 infection with negative results, carried out within 72 or 48 hours before departure, respectively, or the EU Digital COVID Certificate in the form of a test or recovery certificate, as provided in paragraph b) and c), respectively, of point 6 below, without which they will not be allowed to board.
 

5.1. Until January 9, 2022, presentation of proof of vaccination does not exempt the requirement to submit proof of a negative test result.

5.2. The proof of laboratory performance of the rapid antigen test (TRAg) must contain the standard data set defined by the European Union Health Security Committee. Only tests from the general list of rapid antigen tests for Covid-19 screening within the European Union agreed by this Health Security Committee are allowed.
 

5.3. The following are exempted from the requirement of presenting, before boarding, proof of a laboratory nucleic acid amplification test (NAAT) or rapid antigen test (TRAg) for screening for SARS-CoV-2 infection with negative results, carried out within 72 or 48 hours before departure, respectively:
 

  1. Children who have not yet reached 12 years of age;
     
  2. Passengers who are national citizens, foreign citizens with legal residence in mainland Portugal or diplomatic personnel stationed in Portugal on flights originating in the autonomous regions of the Azores and Madeira. However, if their departure to mainland Portugal is to transfer to another country, passengers will have to comply with the destination country's procedures.
     

5.4. Passengers who do not present proof of a SARS-CoV-2 screening test upon arrival in mainland Portugal, or who refuse to submit to such a test, will be subject to a fine of between 300 and 800 Euros.

 

6. The following EU COVID digital certificates are accepted:

  1. A vaccination certificate attesting to the holder's completed vaccination program for at least 14 days with a market-authorized COVID-19 vaccine. The vaccination program is considered complete after the administration:
     
    1. From a single dose of a COVID-19 vaccine with a one-dose vaccination program;
    2. Of the second dose of a COVID-19 vaccine with a two-dose vaccination schedule, even if doses of two distinct vaccines have been administered; or
    3. Of the first dose of a COVID-19 vaccine with a two-dose vaccination schedule by persons who have recovered from the disease, stating on the vaccination certificate that the vaccination schedule was completed after the administration of one dose.
       
  2. A test certificate, attesting that the holder has been subjected to:
     
    1. a nucleic acid amplification molecular test (NAAT), within the last 72 hours, with a negative result;
    2. a rapid antigen test within the last 48 hours, with a negative result;
       
  3. A certificate of recovery, certifying that the holder has recovered from SARS-CoV-2 infection, following a positive NAAT test result, for more than 11 days and less than 180 days.
     

6.1. Vaccination certificates must include, at least, the following information:

  1. First name(s) and surname(s) of the holder;
     
  2. Date of birth;
     
  3. Disease or agent targeted: COVID-19 (SARS-CoV-2 or one of its variants);
     
  4. COVID-19 vaccine or prophylaxis;
     
  5. Name of the vaccine against COVID-19;
     
  6. Marketing authorization holder or manufacturer of the vaccine against COVID-19;
     
  7. The number in a series of doses and the total number of doses in the series;
     
  8. Date of vaccination, indicating the date of the last dose administered;
     
  9. Member State or third country where the vaccine was administered;
     
  10. The entity issuing the certificate.
     

6.2. Recovery certificates must include, at least, the following information:

  1. First name(s) and surname(s) of the holder;
     
  2. Date of birth;
     
  3. Disease or agent from which the holder has recovered: COVID-19 (SARS-CoV-2 or one of its variants);
     
  4. Date of the first positive result of the diagnostic test;
     
  5. Member State or third country in which the diagnostic test was carried out;
     
  6. The entity issuing the certificate; g) Certificate valid since.
     

6.3. Vaccination certificates shall only be recognized as valid if their holders have been inoculated with a vaccine against COVID-19 with marketing authorization in accordance with Regulation (EC) No. 726/2004:

  1. Janssen: COVID-19 Vaccine Janssen;
     
  2. AstraZeneca: Vaxzevria (previously COVID-19 Vaccine AstraZeneca);
     
  3. Moderna: Spikevax (formerly COVID-19 Vaccine Moderna);
     
  4. Pfizer-BioNTech: Comirnaty.
     

6.4. The non-reciprocity in the recognition by third countries of the validity of the EU COVID Digital Certificate, in the modalities of vaccination and recovery certificates, issued by Portugal, prevents the recognition of the validity of certificates issued by these third countries.
 

6.5. Minors traveling with one or both parents or another responsible companion are exempt from quarantine if the companions hold a valid vaccination or recovery certificate when entering the national territory.
 

For more information about the vaccination or recovery certificates, please refer to Decree-Law no. 54-A/2021 of June 25.

 

7. Passengers who, regardless of origin, present a passport with an exit record from Botswana, South Africa, Eswatini, Lesotho, Mozambique, Namibia, and Zimbabwe in the 14 days before their arrival in mainland Portugal, must comply, after entry into mainland Portugal, with a prophylactic isolation period of 14 days, at home or at a place indicated by the health authorities.
Upon arrival in mainland Portugal, these passengers will be forwarded to a designated location inside the airport to perform a nucleic acid amplification test (NAAT) or rapid antigen test (RAT) to screen for SARS-CoV-2 infection and subsequent genomic sequencing, as well as for determination of prophylactic isolation by health authorities.
 

 

These measures regarding air traffic and airports do not apply to:

  • Flights by State and Armed Forces aircraft;
  • Flights of aircraft that are or will be part of the Special Division to Fight Rural Fire;
  • Flights for the exclusive transport of cargo and mail;
  • Flights for humanitarian or medical emergency purposes;
  • Flights for medical emergency purposes;
  • Flights of technical stopovers for non-commercial purposes.
     

 

These guidelines do not exempt the careful reading of Chapter IV (Articles 14 to 17) of the Chapter IV (Articles 18 to 23) of the Council of Ministers Resolution No. 157-A/2021, Order No. 11740-E/2021 of November 26, 2021 and Order No. 11888-C/2021 of November 30, 2021.


This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

COVID-19 screening test with negative result 3 mandatory tests: 1 before departure, 1 on arrival, at the airport, and 1 at Day-8 of the quarantine
Completion of a questionnaire with health and travel information Mandatory through the ArriveCAN app
Need for prophylactic isolation / quarantine A mandatory 14-day quarantine period

 

1. Information to vaccinated passengers

Foreign nationals who qualify for the fully vaccinated traveler exemption can enter Canada for discretionary travel.

Check here if you qualify for the exemption.

 

1.1. To be considered fully vaccinated, passengers must have received the recommended doses of the COVID-19 vaccine accepted by Health Canada. The last dose of the vaccine must have been administered at least 14 days before entry into Canada.
 

Accepted COVID-19 vaccines in Canada

  • Pfizer-BioNTech (Comirnaty, tozinameran, BNT162b2)
  • Moderna (mRNA-1273)
  • AstraZeneca/COVISHIELD (ChAdOx1-S, Vaxzevria, AZD1222)
  • Janssen/Johnson & Johnson (Ad26.COV2.S)
     

Passengers who have recovered from COVID-19 still need a complete series of an accepted COVID-19 vaccine or combination of accepted vaccines. If they’ve only had one dose of an admitted vaccine other than Janssen (Johnson & Johnson), passengers don’t qualify as fully vaccinated.

 

1.2. Passengers must submit the vaccination certificate on the ArriveCAN application before boarding their flight.

 

1.3. Passengers must keep in their possession a copy of the vaccination certificate in paper or electronic format, in English, French, or in a certified translation for sharing with border services, when requested.

 

1.4. Fully vaccinated passengers must also:

  • Submit a negative COVID-19 test result within 72 hours before flight departure or submit a positive test result between 14 and 180 days before flight departure. Antigenic tests are not accepted.
  • Take a COVID-19 test upon arrival, if requested.
  • Have a valid quarantine plan in case the border services deem quarantine necessary.
  • Wear a mask during air travel.
  • Be asymptomatic.
  • Follow any additional guidance recommended by health authorities, including wearing a mask in public for 14 days and keeping a contact list.

 

1.5. If proof of vaccination does not meet all of the requirements, it will be considered invalid, and passengers will be required to:

  • Stay at a government-authorized hotel to await the results of their arrival test before continuing to their place of quarantine.
  • Complete a quarantine period of at least 14 days.
  • Complete a second test on day 8 of the quarantine.


 

2. Mandatory information that passengers must provide


2.1. All passengers five years of age or older, regardless of citizenship, must submit proof of a COVID-19 test result, performed by one of the accepted methodologies, within 72 hours of the scheduled departure time of your flight to Canada.

Tests accepted: CRISPR, Ct, detection of the E gene, detection of the N gene, detection of Orf1a/b, detection of the RdRp gene, detection of the S gene, ddPCR, isothermal amplification, LamPORE, NAAT, NAT, NGS, PCR, qPCR, RNA, RT-LAMP, RT-PCR, sequencing, and WGS.

 

2.1.1. The documentation of the negative laboratory COVID-19 test result must include the following data elements:

  1. the person’s name and date of birth;
  2. the name and civic address of the laboratory that administered the test;
  3. the date the specimen was collected, and the test method used; and
  4. the test result.

 

If passengers have a connecting flight:

  • the test must be conducted within 72 hours of the scheduled departure time of the last direct flight to Canada;
  • passenger may need to schedule the test in the transit city.

 

If passenger have already had COVID-19 and recovered

If now symptom-free, passengers can provide proof of a positive COVID-19 molecular test, instead of a negative one.
This test result will also exempt passengers from the requirement for an arrival test, and from a Day-8 test for those required to quarantine.

  • The test must have been conducted at least 14 and no more than 180 days before the passengers’ initial scheduled departure time of the flight;
  • The proof of the positive result must be from an accepted type of molecular test.
     

All passengers must:

  • provide one of the accepted types of tests, not an antigen test;
  • keep proof of the test results for the 14-day period that begins on the day they enter Canada.
     

Fully vaccinated passengers still have to provide a pre-entry test result.

  • Vaccines accepted are AstraZeneca (Covishield), AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Janssen, Moderna or Pfizer-BioNTech.


 

2.2. When entering Canada, passengers five years of age and older will be required to take a COVID-19 test before exiting the airport, unless directed to use a home test kit. Passengers will also get a kit to use on Day-8 of their mandatory quarantine.

There is no fee for the arrival test.

 

Arrival testing for vaccinated passengers

If passengers qualify for the fully vaccinated traveler exemption, they may be exempt from arrival testing. However, they may be selected for mandatory randomized arrival testing.

 

Arrival testing for unvaccinated passengers

International passengers arriving in Toronto, as well as those connecting to other locations within the Province of Ontario, must perform a COVID-19 screening test upon arrival at Toronto Pearson International Airport, at the testing centers located on the arrivals levels of Terminals 1 and 3.

For a quicker testing experience upon arrival in Toronto, passengers must pre-register before they arrive in Toronto at portal.switchhealth.ca. Passengers should use the same e-mail address they used for their ArriveCAN account.

 

Day-8 test

Fully vaccinated passengers arriving to Canada, who meet all the criteria, no longer need to take a Day-8 test.
 

All passengers will receive calls from a live agent or automated system, and they may also be visited at their place of quarantine by a screening officer to verify compliance.
 

Negative results for the Day-8 test: Passengers can only leave their place of quarantine if they receive a negative result from their Day-8 test AND they have completed their mandatory 14-day quarantine.
 

Positive results on your test: Passengers must isolate themselves from others immediately for a period of 10 days that begins from the time they took the test with positive results (i.e., date/time of specimen collection). A government representative will call them to provide them with additional instructions.
 

Passengers are under a legal obligation to take the arrival and Day-8 tests. Failure to comply with the requirements of the Quarantine Act and emergency orders made under this Act is an offense and could lead to fines of up to $750,000 or imprisonment. If passengers do not take the tests, they may also be transferred to a designated quarantine facility.
 

You can find more information here.


 

2.3. All passengers traveling to Canada, regardless of nationality or citizenship, must, before boarding a flight to the country, submit their travel details, contact information, vaccination information, pre-entry test results, and quarantine plan digitally through the ArriveCAN mobile application, available at the Apple App Store and Google Play, or the website, within 72 hours before their arrival to Canada.
 

Passengers who do not submit the required information through ArriveCAN may be denied boarding.
 

Canadian citizens, permanent residents or persons registered under the Indian Act and foreign nationals eligible to enter Canada under another entry exemption (such as foreign work, study, compassionate grounds) will not be denied boarding or entry, but they:

  • won't be eligible for the fully vaccinated traveler exemption;
  • may face additional delays for public health questioning;
  • may be subject to fines or enforcement action.

 

All passengers arriving in Canada, unless exempt from this requirement, must also continue to submit COVID-19-related information, including a COVID-19 symptom self-assessment, electronically daily throughout the quarantine period.

 

For more information, or if you require assistance, visit Canada.ca/ArriveCAN.
 

2.4. Before boarding an aircraft for a flight to Canada, all passengers must complete a health check by submitting a questionnaire and consent forms.

2.4.1. Every passenger must confirm to the airline that they understand they may be subject to measures to prevent the spread of COVID-19 defined by the federal, provincial, or territorial governments on arrival at their destination.

2.4.2. A competent adult may provide the confirmations on behalf of a person who does not have the ability or competence to do so.

2.4.3. Passengers may be liable to a monetary penalty, up to $5,000, if they provide answers concerning the health check or confirmations that they know to be false or misleading.

 


Do not forget that to enter Canada, you must present a valid visa exemption. Therefore, you must apply for a Travel Authorization at least 72 hours before your departure. You can do it electronically here.


 

3. Restrictions and prevention measures applied by the authorities


3.1. Only passengers under these conditions can enter Canada:

  • Passengers with a COVID-19 vaccination certificate uploaded in ArriveCAN showing that they were fully vaccinated at least 14 days before arrival. Vaccines accepted are AstraZeneca (Covishield), AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Janssen, Moderna, or Pfizer-BioNTech. A combination of vaccines is accepted.
  • Nationals of Canada.
  • Dual nationals of Canada with a Special Authorization approval email.
  • Permanent residents of Canada and their immediate family members.
  • Persons registered under the Canada’s Indian Act with the Certificate of Indian Status (CIS) or the Secure Certificate of Indian Status (SCIS).
  • Passengers with a Canadian Refugee Travel Document or a Single Journey Document for Resettlement to Canada.
  • Immediate family members of nationals of Canada, of permanent residents of Canada and of persons registered under Canada’s Indian Act. They must stay for at least 15 days and have a quarantine plan. Staying for less than 15 days is allowed if they have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 14 days before arrival.
  • Extended family members of nationals of Canada, of permanent residents of Canada and of persons registered under Canada’s Indian Act. They must stay for at least 15 days, have a quarantine plan, and have a written authorization issued by Immigration, Refugees and Citizenship Canada (IRCC). Staying for less than 15 days is allowed if they have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 14 days before arrival.
  • Passengers with an authorization from the Public Health Agency of Canada (PHAC).
  • Passengers with a letter of authorization from the Deputy Minister of Canadian Heritage (PCH).
  • Passengers arriving directly from the USA and traveling on an essential purpose.
  • Passengers with a study permit or a post-graduation work permit, issued by Canada. They must be attending a designated learning institution (DLI) with a COVID-19 readiness plan approved by its province or territory. They must travel to attend their study.
  • Passengers with an application for permanent residence. They must have a written notice issued under the Immigration and Refugee Protection Act;
  • Members of the Canadian forces traveling on duty, and their immediate family members.

 

3.2. Passengers must have a negative COVID-19 test taken at most 72 hours before departure of the last direct flight to Canada.
This does not apply to:

  • Passengers younger than 5 years;
  • Passengers with a positive COVID-19 test taken at least 15 days and at most 180 days before departure of the last direct flight to Canada.

 

3.3. Passengers could be subject to quarantine for 14 days. This does not apply to passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 14 days before arrival, and their accompanying children younger than 12 years.

 

3.4. Passengers are subject to a COVID-19 molecular test on day 1 and day 8 after arrival. This does not apply to:

  • Passengers with a positive COVID-19 test taken at least 15 days and at most 180 days before departure of the last direct flight to Canada;
  • Residents of Point Roberts in Washington in the USA entering Canada to return to their place of residence;
  • Passengers who are members of the Canadian Forces or a visiting force traveling on duty;
  • The COVID-19 molecular test on day 8 after arrival does not apply to passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 14 days before arrival.

 

3.5. Passengers may not be permitted to board if:

  • they exhibit a fever and a cough or a fever and breathing difficulties unless they provide a medical certificate attesting that their symptoms are not related to COVID-19;
  • they have, or suspect that they have, COVID-19;
  • they have been denied permission to board an aircraft in the previous 14 days for a medical reason related to COVID-19;
  • in the case of a flight departing in Canada, they are the subject of a mandatory quarantine order resulting from recent travel or as a result of a local or provincial public health order.

3.5.1. If passengers knowingly provide any false or misleading information about their health, they may be subject to a monetary penalty, up to $5,000.

 

3.6. Passengers aged 2 years old or older must always wear a face mask or cover during the boarding process, in-flight, when exiting the aircraft, and when directed to do so by a gate agent, airport security screening personnel, or a crew member, and when traveling through Canadian airports. Check which masks or facial covers are accepted and allowed by the Canadian authorities here.

  • Children under the age of 2 are not required to wear a non-medical mask or face covering.
  • Between the ages of 2 and 5 years, children are required to wear a non-medical mask or face covering at the time of boarding, during flight, and while disembarking, so long as the child can tolerate it. Children of these ages (or their parents/guardians) must be able to demonstrate they have a mask in their possession when boarding the aircraft, even if the child cannot tolerate wearing it at that time.
  • Children six and older must wear a non-medical mask or face covering when traveling unless their parent or guardian has a medical certificate.

 

3.7. Passengers must arrive at Calgary (YYC), Edmonton (YEG), Halifax (YHZ), Montreal (YUL), Ottawa (YOW), Quebec (YQB), Toronto (YYZ), Vancouver (YVR), or Winnipeg (YWG).

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.

Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
Need for prophylactic isolation / quarantine Subject to measures set by the state or territory of destination.

 

Mandatory information that passengers must provide

 

 

1. All passengers 18 years of age or older non-US citizens, non-US nationals, not legal permanent residents of the US, or traveling to the United States on a non-US immigrant visa, must show proof of being fully vaccinated against COVID-19 before traveling to the United States from a foreign country. Only limited exceptions apply. Learn more about this requirement here.
 

2. All passengers 2 years of age and older, regardless of their vaccination status, nationality, or citizenship, must present a document proving a negative COVID-19 screening test result taken no more than 1 day before travel, which may be an antigen test or a nucleic acid amplification test (NAAT), such as RT-PCR, RT-LAMP, TMA, as approved by the competent national authority in the country where the test is administered, to the airline before boarding a flight to the United States from a foreign country. Otherwise, boarding or entry into the country will be denied.
 

3. Passengers who have recently recovered from COVID-19 will be permitted to travel upon presentation of proof of recovery from COVID-19, which includes a positive result from a COIVID-19 screening test performed on a sample collected within 90 days before departure of the flight to the United States of America, and a signed statement on official letterhead containing the name, address, and telephone number of licensed health care professional or public health authority attesting that the passenger is cleared for travel.
 

4. All passengers with 2 years old or older, regardless of nationality or citizenship, must complete and print the following attestation form before departure, which must be given to the airline when boarding the flight to the United States of America.
 

5. Upon arrival in the United States, public health officials may randomly check the passengers’ COVID-19-related documentation that they were required to show before boarding the flight, which may include the passengers’ COVID-19 test results or documentation of recovery from COVID-19 and proof of COVID-19 vaccination, if applicable.
 

5.1. Every passenger aged 2 years and older may be required to present this documentation, and they must have it, along with their passport, available for inspection.
 

5.2. If the passenger’s proof of COVID-19 vaccination, COVID-19 test result, or your documentation of recovery is digital and on a mobile device, passengers must preload this information or have a screen capture or picture of the documentation on their mobile device for inspection by the public health officials.

 

Further information and clarifications can be found here.

Check here if you can board a flight to the United States.


Do not forget that you must present a valid visa exemption to enter the United States of America. Therefore, you must apply for a Travel Authorization at least 72 hours before your departure. You can do it electronically here.
 

 

Restrictions and prevention measures applied by the authorities

1. Passengers who in the past 14 days have been in, or transited through, Botswana, Eswatini, Lesotho, Malawi, Mozambique, Namibia, South Africa, or Zimbabwe are not allowed to enter the USA.
This does not apply to:

  • Nationals of the USA;
  • Passengers with a Permanent Resident/Resident Alien Card (Form I-551);
  • Spouses of nationals and of residents of the USA;
  • Children of nationals and of residents of the USA, or passengers with an IR-4or IH-4 visa;
  • Parents/guardians of an unmarried and younger than 21 years national or resident of the USA;
  • Brothers/sisters, younger than 21 years, of an unmarried and younger than 21 years national or resident of the USA;
  • Members of the U.S. Armed Forces, their spouses, and children;
  • Passengers with one of the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1 (as an employee of TECRO or TECO or the employee’s immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of those NATO categories);
  • Passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on duty.

 

2. Passengers entering or transiting through the USA must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are:

  • AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart.

    This does not apply to:
    • Nationals of the USA;
    • Residents of the USA;
    • Passengers younger than 18;
    • Passengers with a letter issued by a doctor proving that the passenger is medically unable to receive the vaccine;
    • Passengers with the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1 (as an employee of TECRO or TECO or the employee’s immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of those NATO classifications);
    • Passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on duty;
    • Nationals of Afghanistan. Algeria, Angola, Armenia, Benin, Burkina Faso, Burundi, Cameroon, Central African Rep., Chad, Congo, Congo (Dem. Rep.), Cote d’Ivoire, Djibouti, Egypt, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Libya, Madagascar, Malawi, Mali, Mozambique, Myanmar, Namibia, Nicaragua, Niger, Nigeria, Papua New Guinea, Senegal, Sierra Leone, Solomon Isl., Somalia, South Sudan, Syria, Tanzania, Togo, Uganda, Vanuatu, Yemen, and Zambia, with a visa issued by the USA, excluding B-1 and B-2 visas;
    • Members of the U.S. Armed Forces, their spouses, and children younger than 18 years;
    • Merchant seamen with a C-1 and D visa;
       

More details can be found here.

 

3. Passengers entering or transiting through the USA must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are antigen, NAAT, RT-LAMP, RT-PCR, or TMA. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport or other travel document; and the test result must specify “negative” or “not detected”. If marked “invalid” it is not accepted.

This does not apply to:

  • Passengers younger than 2 years;
  • U.S. military personnel;
  • Passengers with a medical certificate with a positive COVID-19 test result. The test must be taken at most three months before departure from the first embarkation point; and
  • A letter issued by a health authority stating that the passenger has been cleared for travel. The test result must specify “positive” or “detected”. If marked “invalid” it is not accepted;
  • Unvaccinated passengers;
  • Passengers with a COVID-19 recovery certificate proving recovery in the past 90 days.
     

4. Passengers entering or transiting through the USA who are not fully vaccinated must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are antigen, NAAT, RT-LAMP, RT-PCR, or TMA. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document; the test result must specify “negative” or “not detected”. If marked “invalid” it is not accepted.

This does not apply to passengers younger than 2 years.

 

5. Passengers could be subject to self-isolation or self-quarantine for a full 7 days.
This does not apply to:

  • Passengers with a COVID-19 recovery certificate proving recovery in the past 90 days;
  • Passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document.
    Vaccines accepted are:
    • AstraZeneca (SK Bioscience), AstraZeneca (Vxzevria), Covishield, Covaxin, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Cominarty), Sinopharm, and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart.

More details can be found here.

 

6. Federal law requires each passenger two years old or older to wear a mask at all times, throughout the flight, including during boarding and deplaning. Refusing to wear a mask is a violation of federal law and may result in denial of boarding, removal from the aircraft, and/or penalties under federal law.

6.1. The requirement to wear a mask does not apply under the following circumstances:

  • When necessary to temporarily remove the mask for identity verification purposes;
  • While eating, drinking, or taking oral medications for brief periods. Prolonged periods of mask removal are not permitted for eating or drinking; the mask must be worn between bites and sips;
  • While communicating with a person who is deaf or hard of hearing, when the ability to see the mouth is essential for communication;
  • When resorting to oxygen masks;
  • If unconscious (for reasons other than sleeping), incapacitated, unable to be awakened, or otherwise unable to remove the mask without assistance.

 

7. Passengers are subject to COVID-19 measures set by the state or territory of their final destination. More information aqui.

 

8. Upon arrival in the United States, public health officials may randomly check the passengers’ COVID-19-related documentation that they were required to show before boarding the flight, which may include the passengers’ COVID-19 test results or documentation of recovery from COVID-19 and proof of COVID-19 vaccination, if applicable.

8.1. Every passenger aged 2 years and older may be required to present this documentation, and they must have it, along with their passport, available for inspection.

8.2. If the passenger’s proof of COVID-19 vaccination, COVID-19 test result, or your documentation of recovery is digital and on a mobile device, passengers must preload this information or have a screen capture or picture of the documentation on their mobile device for inspection by the public health officials.

 

9. International travelers arriving in the United States are recommended to get a SARS-CoV-2 viral test 3-5 days after travel, regardless of vaccination status.

 

10. Nationals of the USA are allowed to enter with an expired passport. This does not apply to emergency passports which must be valid on arrival.

 

10. DV visas issued in September 2020 that expired are accepted for entry.


This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

You can also find more relevant information here.

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
Need for prophylactic isolation / quarantine Mandatory

 

Mandatory information that passengers must provide

1. Passengers must inform the proper health authority of their address in Germany where they will be staying. To do so, passengers should digitally complete the Digital Registration on Entry, or use the Passenger Locator Card provided by the air carrier.

2. Passengers arriving from or who have been in the last 10 days before arrival in countries with high-risk incidence and variants of concern must register before departure at https://www.einreiseanmeldung.de. You can check a continuously updated list of high-risk areas at www.rki.de/covid-19-risikogebiete.

3. Passengers entering or transiting through Germany, except for passengers younger than 12 years old, must present to the airline, before boarding, a negative COVID-19 test result, taken no more than 48 hours before arrival, proof of vaccination, or proof of recovery.

3.1. Tests accepted are PCR, RT-LAMP and TMA.

3.2. The test result must be in English, French, German, Italian, or Spanish.

3.3. Alternatively, passengers may present a positive COVID-19 PCR, RT-LAMP, or TMA test issued at least 28 days and no more than 6 months before arrival.

 

Restrictions and prevention measures applied by the authorities

1. Temporary travel restrictions apply to all non-essential travel from third countries to Germany.
 

1.1. These travel restrictions do not apply to German citizens and residents of Germany, to passengers from EU member states, to citizens of Andorra, Monaco, San Marino, Switzerland, Vatican City, and member states of the European Economic Area, as well as to passengers who have recently resided and stayed in the following countries and regions:
Australia, Canada, Hong Kong, Jordan, Macau, Moldova, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea, Taiwan, Ukraine, and Uruguay.
 

1.2. Entry into Germany is permitted to all passengers who have resided and last-stayed in third countries, provided they are fully vaccinated against SARS-CoV-2 coronavirus.
Passengers under 12 years of age who have not yet been vaccinated may enter with proof of testing and accompanied by at least one fully vaccinated parent. Mandatory SARS-CoV-2 testing does not apply for children younger than 6 years.

A passenger is considered fully vaccinated under the following conditions:

  1. The vaccine must be listed on the website of the Paul-Ehrlich Institute.
  2. Passengers must have received all the necessary vaccination doses required for a complete protective vaccination, as listed on the website of the Paul-Ehrlich Institute.
  3. At least 14 days have elapsed since the last required vaccination, except for recovered persons.
  4. Passenger has not stayed in an area of variants of concern during the last 10 days.
  5. Passengers have a COVID-19 vaccination certificate showing that you have been vaccinated with the full doses from AstraZeneca (Vaxzevria), Janssen, Moderna, or Pfizer-BioNTech (Comirnaty) at least 14 days before departure. The certificate must be in English, French, German, Italian, or Spanish.
  6. Passengers have a COVID-19 vaccination certificate, proving that they have received the first dose of vaccine from AstraZeneca (Vaxzevria), Moderna, or Pfizer-BioNTech (Comirnaty) at least 14 days before departure, and a COVID-19 recovery certificate issued at least 6 months before the first dose of vaccine. Certificates must be in English, French, German, Italian, or Spanish.
  7. Passengers under 12 years old traveling accompanied by a parent with a COVID-19 vaccination certificate showing that the parent received the first dose of vaccine from AstraZeneca (Vaxzevria), Moderna, or Pfizer-BioNTech (Comirnaty) at least 14 days before departure, and with a COVID-19 recovery certificate issued at least 6 months before the first dose of vaccine. Certificates must be in English, French, German, Italian, or Spanish.
  8. Passenger is a citizen of a state whose entry requirements are not subject to reciprocity. Reciprocity reservations currently exist for the following State: China.
     

1.2.1. Passengers must present a digital COVID certificate of the European Union (EU-DCC) or equivalent proof of vaccination before departure to the carrier, which must check it against an ID card or equivalent before boarding.

The vaccination certificate must contain at least the following information:

  1. Personal data of the vaccinated person (at least surname, first name, and date of birth),
  2. Date of vaccination,
  3. Number of vaccination doses,
  4. Name of the vaccine,
  5. Name of the disease against which vaccination was received, and
  6. Characteristics that indicate the person or institution responsible for carrying out the vaccination or issuing the certificate. For example, an official symbol or the name of the issuer.
  7. Accepted languages of proof of vaccination: German, English, French, Italian or Spanish.
     

1.3. Entry into Germany is permitted to all passengers from third countries who have an imperative reason for travel:

  1. EU citizens and third-country nationals with current right of residence in Germany,
  2. Healthcare workers, health researchers, and geriatric-care workers,
  3. Skilled and highly qualified foreign workers if their employment is necessary from an economic perspective and the work cannot be postponed or performed abroad,
  4. Freight transport and other transport personnel,
  5. Seasonal workers in agriculture,
  6. Seafarers,
  7. Foreign national students, trainees, volunteers,
  8. Persons immigrating into Germany to join their families and visits for urgent family reasons or short-term visits of core family members (husband/wife, minor children, parents of minor children) or unmarried partners in a relationship with German nationals, EU citizens, and third-country nationals with current right of residence in Germany or joint short-term visits of couples (third-country national and German national / EU citizen) residing together in a third country for significant reasons,
  9. Persons in need of international protection or for other humanitarian reasons,
  10. Diplomats, staff of international organizations, military personnel, and humanitarian aid workers in the exercise of their functions,
  11. Ethnic German resettlers,
  12. Passengers in transit.
     

1.4. Entry from third countries into Germany for the sole purpose of onward travel to another EU/Schengen state is permitted. The following conditions apply:

  1. The time spent in Germany is limited to the duration required for direct transit to the destination state,
  2. The third-country national is permitted to enter the destination state per Annex I or Annex II of the Council Recommendation (EU) 2020/912 of 30 June 2020 or an individual confirmation of the granting of entry issued by the destination state.
  3. The third country is not designated as an area of variants of concern.
     

Under these conditions, entering by air and onward travel to the country of destination by land is also permitted.

It is the passenger’s responsibility to prove the right of entry into the country of destination and the travel route if controls occur.
 

2. Passengers arriving from or who have been in a country or area considered to be a risk area in the 10 days before arrival in the Federal Republic of Germany must:
 

2.1. Register on arrival: Passengers who have been in an area considered a risk area must complete the digital registration at www.einreiseanmeldung.de and have the confirmation with them when arriving in Germany. The confirmation will be checked by the airline before boarding and may also be checked by the Federal Police as part of their responsibilities as a border control agency.
 

2.2. Present proof: Passengers arriving in Germany after a stay in the last 10 days in a risk area must present a negative test result, proof of vaccination, or recovery. Without this proof, boarding will be denied.

Passengers arriving from or having been in the last 10 days in an area with variants of concern must have in their possession a negative test result, even if they have a vaccination or recovery certificate, and present this proof to the airline before boarding.

These proofs must be uploaded via the travel portal at einreiseanmeldung.de.
 

2.3. Undertake mandatory quarantine: Passengers who arrive from or have been in a risk area must go directly to their home or other accommodation at their destination on arrival and remain there in isolation for ten days.
Passengers who arrive from or have been in an area with variants of concern before arriving in Germany must remain in quarantine for 14 days.
 

2.3.1. Quarantine may be reduced on presentation of a new negative SARS-CoV-2 screening test result. For passengers arriving from or having been in a high incidence area before entering the country, the new test cannot be performed until the fifth day after arrival. For persons under 12 years of age, the quarantine automatically concludes at the end of the fifth day after entry.
If arriving from an area with variants of concern, the duration of quarantine may not be shortened unless the area in question is no longer listed at www.rki.de/risikogebiete. For now, the quarantine obligation is determined to last until September 30, 2021.

More information is available here.
 

3. Since each Federal State implements its regulations, you should inform yourself about the provisions in effect in the State that you are entering and/or staying in. The local health authority will monitor compliance with quarantine requirements. You can find the local health authority online at tools.rki.de/plztool/.
 

4. Even if test results are negative, passengers are legally required to contact the local health authority immediately, if they develop typical symptoms of a Coronavirus SARS-CoV-2 infection (shortness of breath, newly developed cough, fever, or loss of taste/smell) within 10 days of arrival. You can find the local health authority online at https://tools.rki.de/plztool.
 

5. The European Aviation Safety Agency (EASA) recommends the use of a protective mask from the age of 6 years. Within Germany, it is mandatory to wear one from the age of 6 years.


This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

Valid Covid Certificate of Testing, Recovery or Vaccination with complete vaccination schedule, or negative RT-PCR or antigen test result Mandatory
Completion of a questionnaire with health and travel information Mandatory

 

Mandatory information that passengers must provides

Passengers must complete online the surveillance and health control form.

 

Restrictions and prevention measures applied by the authorities

1. Passengers who intend to disembark in Cape Verde are required to present a negative RT-PCR test result, or a negative antigen (Ag-RDT) test result, or any other molecular test validated by the health authorities, carried out within a maximum period of 48 hours before boarding, under penalty of being denied boarding or entry into the country.

 

2. Accepted vaccines and certificate validity:

  • AstraZeneca, Moderna, Pfizer, Sinopharm, Sputnik V (14 days from 2nd dose)
  • Johnson & Johnson (28 days from single dose)

 

Exceptions:

a) Passengers in transit or transfer, who do not cross the national border, are exempted from any molecular test (RT-PCR or other) or antigen test (Ag-RDT), without prejudice to compliance with other measures determined by health authorities.

b) Children under seven years of age.

 

3. In international air travel, verification of the ownership of a valid COVID Test, Recovery or Vaccination Certificate as a complete vaccination schedule or a negative RT-PCR or antigen test result is carried out at departure and arrival times, by airlines, health and airport authorities as a condition for boarding or disembarkation.

 

You can find more information here.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

 

Additional information for passengers traveling from Cape Verde to China

All passengers of Chinese and foreign nationality flying from Cape Verde to the People’s Republic of China as the final destination are required to perform a nucleic acid and IgM antibody test and, then, request from the Chinese Embassy in Cape Verde a green health code, with an HS symbol (for Chinese citizens) or a health declaration form, with an HDC symbol (for foreign citizens) before boarding the flight leaving Cape Verde, whether a direct or a connecting flight.

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
Need for prophylactic isolation / quarantine Applicable to passengers arriving from countries on the orange and red lists

 

Mandatory information that passengers must provide


If passengers are vaccinated:

Vaccinated passengers can travel to France with no restrictions linked to health conditions.

The measures applicable to vaccinated adults also apply to any minors accompanying them, whether they are vaccinated or not. Passengers can therefore travel with their underage children whether they are vaccinated or not, and they will not need to self-isolate. Unvaccinated children 12 years of age and older will need to have a negative result of a COVID-19 screening test before boarding.

 

Vaccinated passengers must present the following travel documents:

1. Proof of vaccination.

It will only be valid if it proves that the passenger is fully vaccinated, i.e.,

  • Seven days after the second shot for two-shot vaccines (Pfizer, Moderna, AstraZeneca (Vaxzevria and Covishield));
  • Four weeks after the shot for one-shot vaccines (Johnson & Johnson);
  • Seven days after the shot for vaccines administered to people who have already had COVID-19 (only one dose is necessary);
  • Seven days after a booster ARNm dose (Moderna or Pfizer) after two shots of a vaccine on the WHO’s health emergencies list (Sinovac/Coronavac or Sinopharm/BBIB-PVeroCells).

Only vaccines authorized by the European Medicines Agency (EMA) will be accepted, i.e., Pfizer (Comirnaty), Moderna, AstraZeneca (Vaxzevria), Johnson & Johnson (Janssen), and AstraZeneca (Covishield).
 

To simplify travel of non-European passengers in France, the Ministry for Europe and Foreign Affairs set up a specific mechanism for issuing a COVID vaccine certificate of equivalence which is valid on French territory.
This system, available here, is open to non-European foreign nationals, tourists and students enrolled in French higher education establishments.
You can find more information here

2. A sworn declaration, that can be downloaded here, stating that:

  • passengers have no symptoms of COVID-19 infection;
  • to their knowledge, passengers have not been in contact with a confirmed case of COVID-19 in the 14 days before their journey.

 

Starting on December 15, passengers 65 and older or who were vaccinated with a Janssen vaccine must provide proof of booster vaccination for their COVID certificate to be extended.

 

If passengers are not vaccinated

Depending on their circumstances, non-vaccinated passengers must complete and carry the following documents to board:

1. A sworn declaration, which can be downloaded here, stating that:

  • passengers have no symptoms of COVID-19 infection;
  • to their knowledge, passengers have not been in contact with a confirmed case of COVID-19 in the 14 days before their journey;
  • If passengers are aged 12 years or older, they agree to submit to a virological RT-PCR test for SARS-CoV-2 upon arrival in France;
  • Where applicable, passengers pledge to self-isolate for seven days;
  • For non-vaccinated passengers arriving from a red-listed country, passengers are aware that they will have to quarantine for ten days upon arrival in France.
     

2. An exempted international travel certificate for Metropolitan France, which can be downloaded here. Passengers must present this certificate to travel companies before using their travel ticket, as well as to border control authorities (for travel by air, sea, and land, including by rail).
 

3. Proof of location of self-isolation, and where appropriate, access details for inspectors to carry out checks.

 

Passengers will not be allowed to board without these documents.

 

Restrictions and prevention measures applied by the authorities


If passengers are vaccinated:

Vaccinated passengers can travel to France with no restrictions linked to health conditions.

The measures applicable to vaccinated adults also apply to any minors accompanying them, whether they are vaccinated or not. Passengers can therefore travel with their underage children whether they are vaccinated or not, and they will not need to self-isolate. Unvaccinated children 12 years of age and older will need to have a negative result of a COVID-19 screening test before boarding.
 

If passengers are not vaccinated:

A list of countries of departure has been drawn up based on health indicators. The lists of countries can be altered based on changes in the epidemic situation.
Check the countries on the "green", "orange" and "red" lists here.
 

Non-vaccinated passengers arriving from a green-listed country

1. Upon boarding, each passenger aged 12 years or older must present a negative PCR or antigenic test taken less than 72 hours before the flight.

For passengers traveling from Austria, Belgium, Bulgaria, Croatia, Estonia, Germany, Greece, Hungary, Ireland, Latvia, Lithuania, Luxembourg, the Netherlands, Poland, the Czech Republic, Romania, Slovakia, Slovenia, and Switzerland, the test must have been performed less than 24 hours before the flight.
 

If passengers have previously contracted COVID-19, instead of a negative test result, they may present a recovery certificate dated more than 11 days and less than 6 months before the date of arrival. A recovery certificate is a document issued to persons who have contracted COVID-19 upon a positive RT-PCR or antigenic test.
 

Exemptions:

  • Work-related trips, since the urgent or frequent nature of which makes them incompatible with these tests.

To avail of this exemption, passengers must have a document proving the reasons for their trip.
 

Non-vaccinated passengers arriving from an orange-listed country

1. Passengers can only travel to France if they have pressing grounds for travel. The list of pressing reasons is set out in the certificate of international travel drawn up by the Ministry of the Interior.
 

2. Each passenger aged 12 years or older must present a negative PCR test taken less than 72 hours before departure or a negative antigenic test taken less than 48 hours before departure.

For passengers arriving from the United Kingdom, the PCR or antigenic test must have been performed less than 24 hours before boarding.
If passengers have previously contracted COVID-19, instead of a negative test result, they may present a recovery certificate dated more than 11 days and less than 6 months before the date of arrival. A recovery certificate is a document issued to persons who have contracted COVID-19 upon a positive RT-PCR or antigenic test.
 

3. Passengers may be subject to a random test when arriving in France.
 

4. Passengers must pledge to self-isolate for seven days.

 

Non vaccinated passenger arriving from a red-listed country

1. Passengers can only travel to France if they have pressing grounds for travel. The list of pressing reasons is set out in the certificate of international travel drawn up by the Ministry of the Interior.
 

2. Upon boarding, each passenger aged 12 years or older must present a negative PCR or antigenic test taken less than 48 hours before the flight.
If passengers have previously contracted COVID-19, instead of a negative test result, they may present a recovery certificate dated more than 11 days and less than 6 months before the date of arrival. A recovery certificate is a document issued to persons who have contracted COVID-19 upon a positive RT-PCR or antigenic test.
 

3. Passengers will be tested again when arriving in France.
 

4. Passengers will be subject to a mandatory 10-day quarantine supervised by security forces.

 

Regardless of the place of departure, if passengers show symptoms of COVID-19 upon arrival in France, they will be quarantined or placed and kept isolated by the authorities.

 

During their stay in France, passengers should download and activate the TousAntiCovid application, available here.

The European Aviation Safety Agency (EASA) recommends using a protective mask from the age of 6 years. Its use is mandatory within France from the age of 11 years.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.

 

Top

Loading...